| Financial Year |
March 31 2023 |
| Monetary Funds |
91,222,724.33 |
| Held-for-trading Financial Assets |
15,458,657.24 |
| Notes Receivable |
105,376.00 |
| Accounts Receivable |
81,307,722.54 |
| Advances to Suppliers |
17,902,561.65 |
| Other Receivables |
6,532,950.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,438,174.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,062,168,166.65 |
| Total Current Assets |
1,307,548,812.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,333,100.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
377,645.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,355,414.16 |
| Deferred Income Tax Assets |
8,514,339.72 |
| Other Non-Current Assets |
11,188,500.82 |
| Sub-Total of Non-Current Assets |
43,612,110.40 |
| Total Assets |
1,351,160,922.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,696,501.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,435,824.35 |
| Taxes Payable |
5,963,817.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,305,180.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,773,441.57 |
| Other Current Liabilities |
1,225,690.92 |
| Sub-Total of Current Liabilities |
63,700,826.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,356,452.07 |
| Deferred Income Tax Liabilities |
14,274.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,321,269.93 |
| Total Liabilities |
82,022,096.46 |
| Paid-In Capital(Or Share Stock) |
204,750,000.00 |
| Capital Surplus |
568,922,787.49 |
| Surplus Reserve |
56,602,776.37 |
| LESS:Treasury Stock |
6,001,908.00 |
| Undistributed Profits |
445,057,071.17 |
| Minority Stockholder's Interest |
-191,900.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,269,330,727.03 |
| Owner's Equity（Stockholder's Equity） |
1,269,138,826.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,351,160,922.60 |
